Physician profile
Faisal Aziz
NPI 1669601332
$59,365.55
in general payments reported to CMS, 2019-2025
27 companies · $4,008 in 2025
The $4,008 reported for 2025 was more than what 82% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,152 · 2020: $1,104 · 2021: $436 · 2022: $20K · 2023: $13K · 2024: $11K · 2025: $4,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $8,547 · Consulting Fee: $850 · Travel and Lodging: $134 · Education: $1.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,817.00 |
| Food and Beverage | $8,546.88 |
| Consulting Fee | $850.00 |
| Travel and Lodging | $133.88 |
| Education | $1.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $36,241.20 | 2020-2024 | Xarelto |
| Medtronic Vascular, INC. | $8,852.79 | 2019-2020 | |
| Medtronic, INC. | $5,441.56 | 2022-2025 | Endurant Iis, Heli-Fx Endoanchor System, Valiant Captivia |
| Silk Road Medical, INC. | $1,745.59 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $1,626.72 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin |
| Convatec INC. | $850.00 | 2025 | |
| Endologix LLC | $798.82 | 2022-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Penumbra, INC. | $725.12 | 2023-2025 | Indigo System, Penumbra System |
| Shockwave Medical, INC | $488.11 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cook Medical LLC | $468.77 | 2019-2023 | Cook, Zilver Ptx |
| Limflow INC. | $404.63 | 2023 | Limflow System |
| Lemaitre Vascular, INC. | $339.72 | 2022-2025 | Restoreflow, Artegraft Vascular Graft |
| Inari Medical, INC. | $197.84 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Humacyte Global, INC. | $185.45 | 2025 | Symvess |
| Bard Peripheral Vascular, INC. | $173.70 | 2019-2024 | Crosser Iq |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $166.97 | 2025 | Enroute Transcarotid Neuroprotection System |
| Abbott Laboratories | $120.58 | 2022 | |
| Bolton Medical INC | $99.15 | 2025 | Treo Abdominal Stent-Graft System |
| Janssen Scientific Affairs, LLC | $96.20 | 2022-2023 | Xarelto |
| Sanara Medtech INC. | $90.75 | 2024 | Celleraterx |
| Cvrx, INC. | $82.93 | 2021-2024 | Barostim Neo System |
| Astrazeneca Pharmaceuticals Lp | $66.09 | 2019 | |
| Cardiva Medical, INC. | $26.68 | 2025 | Cardiva Vascade 6/7f Vcs |
| Acera Surgical, INC. | $24.23 | 2025 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $18.77 | 2022 | |
| Baxter Healthcare | $17.90 | 2022 | |
| Tactile Systems Technology INC | $15.28 | 2023 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faisal Aziz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.